A new and astonishing development has been revealed as the Pyxis Ocean has been testing the WindWing system, which provides ...

C&C Marine and Repair has delivered the M/V Al Sloss to Canal Barge Company, completing the first vessel in a four-boat ...

PaxOcean Group and ABB have announced that Singapore’s first fully electric tug completed commissioning, marking a major ...

Baystreet.ca News Commentary – The war on cancer is moving into a high-tech era of molecular-guided defense. The genomics in ...

Let’s not undermine trust in the system by making those who have the least money in their super pay for losses in risky, ...

A comprehensive analysis of 2025’s most awarded cameras and gear based on independent industry and editorial awards.

Defence became one of the ASX’s biggest themes in 2025, and in 2026 investors will be watching who can turn ... Read More The post Defence became a key theme in 2025, with three ASX stocks worth ...

Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...

BOSTON - Pyxis Oncology, Inc. (NASDAQ:PYXS) announced preliminary data from ongoing Phase 1 clinical studies of its antibody-drug conjugate micvotabart pelidotin (MICVO) in patients with ...

Investing.com -- Pyxis Oncology Inc (NASDAQ:PYXS) stock tumbled 49.9% in premarket trading Thursday after investors expressed disappointment with preliminary data from the company’s experimental ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

46% confirmed objective response rate (ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR and 100% DCR observed with MICVO in ...